Working... Menu

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02661464
Recruitment Status : Active, not recruiting
First Posted : January 22, 2016
Last Update Posted : April 24, 2019
Bavarian Nordic GmbH
Information provided by (Responsible Party):
Janssen Vaccines & Prevention B.V.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 1, 2022
  Estimated Study Completion Date : April 11, 2023